Ligand Pharmaceuticals Incorporated
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $120.6M
Liabilities Breakdown FY2011
Total Liabilities: $104.1M
Asset Breakdown
Total Assets: $120.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.0M | 5.8% |
| Accounts Receivable | $6.1M | 5.1% |
| Inventory | $1.3M | 1.1% |
| Property, Plant & Equipment | $455.0K | 0.4% |
| Goodwill | $12.2M | 10.1% |
| Intangible Assets | $58.3M | 48.4% |
| Other Assets | $35.1M | 29.1% |
Liabilities Breakdown
Total Liabilities: $104.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.1M | 10.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $93.0M | 89.4% |